Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Regulatory News (AMYT)

  • There is currently no data for AMYT

Director/PDMR Shareholding

20 Aug 2014 07:00

RNS Number : 5639P
Fastnet Oil & Gas PLC
20 August 2014
 

Fastnet Oil & Gas plc

("Fastnet" or the "Company")

Grant of options

 

20 August 2014

 

The Company announces that options over a total of up to 5,000,000 new ordinary shares of 3.8 pence each in the Company ("Options") have today been awarded to Will Holland, Chief Financial Officer. The Options have an exercise price of 14 pence per ordinary share.

 

The Options vest in four tranches over the period to 1 May 2016 and lapse 2 years after vesting. The Options may only be exercised during the 2 year window if, during that period, the share price exceeds a specific performance target (as set out in the table below).

 

Options

Exercise Price

Vesting Date

Lapse date

Share Price Target

1,000,000

14p

1/10/2014

1/10/2016

17.5p

1,500,000

14p

1/5/2015

1/5/2017

21p

1,500,000

14p

1/11/2015

1/11/2017

24.5p

1,000,000

14p

1/5/2016

1/5/2018

31.5p

 

Will Holland currently does not have an interest in the ordinary shares of the Company.

 

For further information please contact:

Fastnet Oil & Gas plc

Cathal Friel, Chairman

Paul Griffiths, Managing Director

+353 (1) 644 0007

 

Shore Capital

Nomad

Bidhi Bhoma, Edward Mansfield

 

Corporate Broking

Jerry Keen

+44 (0) 20 7408 4090

 

GMP Securities Europe LLP

(Joint Broker)

Rob Collins, Emily Morris, Liz Williamson

 

+44 (20) 7467 2800

 

 

Davy

(ESM Adviser & Joint Broker)

John Frain, Anthony Farrell

 

+353 (1) 679 6363

 

Bell Pottinger

Philip Dennis, Rollo Crichton-Stuart, Jimmy Lea

 

+44 (0) 0203 772 2734

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSFUFMUFLSEEA
Date   Source Headline
19th Feb 202012:00 pmRNSDraft registration statement for US Nasdaq listing
15th Jan 20205:16 pmRNSHolding(s) in Company
15th Jan 20207:00 amRNSAmryt to present updates from its EB research
7th Jan 202012:09 pmRNSPDMR Dealings
30th Dec 201911:07 amRNSHolding(s) in Company
27th Dec 20198:00 amRNSEuronext Growth Dublin Notice
23rd Dec 201911:22 amRNSHolding(s) in Company
20th Dec 20192:40 pmRNSExercise of Warrants & Issue of Ordinary Shares
19th Dec 20197:00 amRNSBusiness integration and synergies on track
26th Nov 20197:00 amRNSHoldings in Company
18th Nov 20197:00 amRNSHoldings in Company
14th Nov 20194:31 pmRNSShare Buyback
5th Nov 20196:16 pmRNSGrant of Options
5th Nov 20197:00 amRNSTrading Update
4th Nov 20197:00 amRNSNotice of Trading Update
28th Oct 20194:58 pmRNSHolding(s) in Company
3rd Oct 20194:38 pmRNSHoldings in Company
1st Oct 20197:00 amRNSAP101 Receives Fast Track Designation from FDA
30th Sep 20194:30 pmRNSHalf-year Report
30th Sep 20197:00 amRNSInvestor Events Update
30th Sep 20197:00 amRNSHolding(s) in Company
25th Sep 20197:00 amRNSCompletion of Acquisition and $60m equity raised
24th Sep 201912:30 pmRNSSchedule One Update - Amryt Pharma Plc
24th Sep 20198:29 amRNSSchedule One Update
24th Sep 20197:30 amRNSSuspension - Amryt Pharma Plc
23rd Sep 20192:15 pmRNSCourt Sanction of the Scheme of Arrangement
20th Sep 20198:00 amRNSEuronext Growth Dublin Notice
19th Sep 20191:30 pmRNSResults of Court Meeting and General Meeting
13th Sep 20197:00 amRNSCircular to Shareholders
11th Sep 20193:00 pmRNSUpdate on Acquisition of Aegerion
5th Sep 20192:30 pmRNSSchedule One
5th Sep 20192:30 pmRNSSchedule One - Amryt Pharma plc
4th Sep 20198:00 amRNSEuronext Growth Dublin Suspension Notice
4th Sep 20197:00 amRNSSuspension of Trading on Euronext
3rd Sep 20191:00 pmRNSHoldings in Company
30th Aug 20193:06 pmRNSHolding(s) in Company
30th Aug 20198:00 amRNSEuronext Growth Dublin Notice
30th Aug 20197:00 amRNSDirector/PDMR Shareholding
27th Aug 20191:00 pmRNSRestoration - Amryt Pharma Plc
27th Aug 20191:00 pmRNSEuronext Growth Dublin Restoration Notice
27th Aug 20191:00 pmRNSPublication of Admission Document and Circular
10th Jul 201911:23 amRNSResult of AGM
12th Jun 20197:00 amRNSPosting of Annual Report and Notice of AGM
22nd May 20196:24 pmRNSGrant of Options
21st May 20197:30 amRNSEuronext Growth Dublin Suspension Notice
21st May 20197:30 amRNSSuspension - Amryt Pharma plc
21st May 20197:00 amRNSRecommended Acquisition of Aegerion
17th Apr 20197:00 amRNSPreliminary Results and Q1 Trading Update
12th Apr 201910:04 amRNSNotice of Results
28th Feb 20197:00 amRNSUpdate on AP101 EASE Phase III trial

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.